Literature DB >> 9054423

A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors.

J Cheng1, K Wu, M Armanini, N O'Rourke, D Dowbenko, L A Lasky.   

Abstract

Here we describe a novel member of the receptor-like protein-tyrosine phosphatases (PTPs) termed PTP lambda, which is homologous to the homotypically adherent PTPs kappa and mu. Murine PTP lambda contains MAM, IgG, fibronectin type III, and dual phosphatase domains. As has been demonstrated for PTPs kappa and mu, PTP lambda mediates homotypic adhesion in vitro, and PTP lambda is associated with beta catenin in kidney epithelial cells. The extracellular domain of PTP lambda is proteolytically processed in cell culture as well as in vivo. Northern blot analysis reveals that PTP lambda is expressed throughout embryonic development and is predominately found in adult brain, lung, and kidney. In situ hybridization to 15.5-day old rat embryos reveals that PTP lambda is expressed in a variety of embryonic neuronal sites as well as in the esophagus, lung bronchiolar epithelium, kidney glomerular epithelium, olfactory epithelium, and various cartilagenous sites. Analysis of neonatal brain demonstrates expression in cells of the hippocampus, cortex, and the substantia nigra. Finally, immunohistochemical analysis reveals expression of this PTP on specific neurons of the spinal cord as well as on isolated cortical neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054423     DOI: 10.1074/jbc.272.11.7264

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

2.  Rho GTPases regulate PTPmu-mediated nasal neurite outgrowth and temporal repulsion of retinal ganglion cell neurons.

Authors:  Denice L Major; Susann M Brady-Kalnay
Journal:  Mol Cell Neurosci       Date:  2007-01-17       Impact factor: 4.314

3.  Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases.

Authors:  Scott Becka; Peng Zhang; Sonya E L Craig; David T Lodowski; Zhenghe Wang; Susann M Brady-Kalnay
Journal:  Cell Commun Adhes       Date:  2010-04

4.  The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.

Authors:  M J Wallace; C Fladd; J Batt; D Rotin
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages.

Authors:  F J Pixley; P S Lee; J S Condeelis; E R Stanley
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 6.  Regulation of signaling by protein-tyrosine phosphatases: potential roles in the nervous system.

Authors:  C O Arregui; J Balsamo; J Lilien
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

7.  Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity.

Authors:  Lars Anders; Philipp Mertins; Sven Lammich; Marta Murgia; Dieter Hartmann; Paul Saftig; Christian Haass; Axel Ullrich
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

8.  Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia.

Authors:  Xiu Fen Sui; Timothy D Kiser; Sang Won Hyun; Daniel J Angelini; Robert L Del Vecchio; Bradford A Young; Jeffrey D Hasday; Lewis H Romer; Antonino Passaniti; Nicholas K Tonks; Simeon E Goldblum
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 9.  Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

10.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.